Nasal Spray Lowers Covid Viral Load By 94% In 24 Hours: Lancet Study - NDTV

A nasal spray administered in high-risk adult Covid patients in India reduced viral load by 94% within 24 hours and 99% in 48 hours, according to the results of phase 3 trial of the drug published in The Lancet Regional Health Southeast Asia journal.

The COVID-19 nasal spray study was published in The Lancet Regional Health Southeast Asia journal New Delhi: A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral lo… [+2338 chars]

full article...